World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
93
Citations
34530
World Ranking
10821
National Ranking
5570

Overview

Bernd Schnabl is affiliated with the University of California, San Diego in the United States. Their research primarily focuses on medicine, with a substantial body of work in biochemistry, genetics, and molecular biology. Schnabl's expertise spans several subfields including epidemiology, molecular biology, pathology and forensic medicine, hepatology, and surgery.

The main topics Schnabl investigates address various aspects of liver health and disease. These include:

  • Liver Disease Diagnosis and Treatment
  • Alcohol Consumption and Health Effects
  • Gut microbiota and health
  • Diet, Metabolism, and Disease
  • Diet and metabolism studies
  • Liver Disease and Transplantation
  • Pancreatitis Pathology and Treatment

Schnabl has contributed numerous articles to key journals in hepatology and related fields. The most frequent publication venues are:

  • Journal of Hepatology
  • Hepatology Communications
  • Liver International
  • Gastroenterology
  • Hepatology

Among Schnabl's recent papers are the following:

  • The gut-liver axis and gut microbiota in health and liver disease, 2023, Nature Reviews Microbiology
  • Gut microbiome, liver immunology, and liver diseases, 2020, Cellular and Molecular Immunology
  • The microbiota in cirrhosis and its role in hepatic decompensation, 2021, Journal of Hepatology
  • Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma, 2020, Cancer Discovery
  • Microbiota and Fatty Liver Disease-the Known, the Unknown, and the Future, 2020, Cell Host & Microbe

Schnabl frequently collaborates with several coauthors, notably:

  • Peter Stärkel
  • Phillipp Hartmann
  • Yi Duan
  • Yanhan Wang
  • Bei Gao

Best Publications

  • Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth.

    Sergei I. Grivennikov;Kepeng Wang;Daniel Mucida;C. Andrew Stewart

  • New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

    Zhenyu Zhong;Shuang Liang;Elsa Sanchez-Lopez;Feng He

  • The gut–liver axis and the intersection with the microbiome

    Anupriya Tripathi;Anupriya Tripathi;Justine Debelius;David A. Brenner;Michael Karin

  • Bacterial infections in cirrhosis: A position statement based on the EASL Special Conference 2013

    Rajiv Jalan;Javier Fernandez;Reiner Wiest;Bernd Schnabl

  • Interactions between the intestinal microbiome and liver diseases.

    Bernd Schnabl;David A. Brenner

  • Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

    Rohit Loomba;Victor Seguritan;Weizhong Li;Tao Long

  • Enteric dysbiosis associated with a mouse model of alcoholic liver disease

    Arthur W. Yan;Derrick E. Fouts;Johannes Brandl;Johannes Brandl;Peter Stärkel

  • Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice

    Kouichi Miura;Kouichi Miura;Yuzo Kodama;Sayaka Inokuchi;Bernd Schnabl

  • Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

    Yi Duan;Yi Duan;Cristina Llorente;Cristina Llorente;Sonja Lang;Katharina Brandl

  • Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits

    Katharina Brandl;George Plitas;Coralia N. Mihu;Coralia N. Mihu;Carles Ubeda

  • Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

    Sungsoon Fang;Jae Myoung Suh;Shannon M Reilly;Elizabeth Yu

  • Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis

    Mauro Bernardi;Richard Moreau;Richard Moreau;Paolo Angeli;Bernd Schnabl;Bernd Schnabl

  • MyD88-mediated signals induce the bactericidal lectin RegIIIγ and protect mice against intestinal Listeria monocytogenes infection

    Katharina Brandl;George Plitas;Bernd Schnabl;Ronald P. DeMatteo

  • Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut.

    Ekihiro Seki;Bernd Schnabl

  • Intestinal fungi contribute to development of alcoholic liver disease

    An Ming Yang;Tatsuo Inamine;Tatsuo Inamine;Katrin Hochrath;Peng Chen

  • Acute-on-chronic liver failure in cirrhosis.

    Vicente Arroyo;Richard Moreau;Patrick S. Kamath;Rajiv Jalan

  • Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity.

    Kouichi Miura;Kojiro Taura;Yuzo Kodama;Bernd Schnabl

  • Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease

    Derrick E. Fouts;Manolito Torralba;Karen E. Nelson;David A. Brenner

  • FXR Regulates Intestinal Cancer Stem Cell Proliferation.

    Ting Fu;Sally Coulter;Eiji Yoshihara;Tae Gyu Oh

  • The role of Smad3 in mediating mouse hepatic stellate cell activation

    Bernd Schnabl;Young O. Kweon;Joshua P. Frederick;Xiao‐Fan Wang

Frequent Co-Authors

David A. Brenner
David A. Brenner University of California, San Diego
Samuel B. Ho
Samuel B. Ho Mohammed Bin Rashid University of Medicine and Health Sciences
Rohit Loomba
Rohit Loomba University of California, San Diego
Derrick E. Fouts
Derrick E. Fouts J. Craig Venter Institute
Ramon Bataller
Ramon Bataller University of Pittsburgh
Claus Hellerbrand
Claus Hellerbrand University of Erlangen-Nuremberg
Claude B. Sirlin
Claude B. Sirlin University of California, San Diego
Tatiana Kisseleva
Tatiana Kisseleva University of California, San Diego
Guadalupe Garcia-Tsao
Guadalupe Garcia-Tsao Yale University
Hidekazu Tsukamoto
Hidekazu Tsukamoto University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the world of medicine opens the door to many alternative degrees and career paths beyond the traditional MD. Many students consider related healthcare programs that offer greater flexibility, such as the CAHME-accredited MHA programs for those interested in healthcare administration.

For nurses seeking to advance their credentials quickly, there are RN to BSN programs without clinicals that allow working professionals to upskill online without on-site requirements. Aspiring nurse leaders who want to earn a doctorate efficiently can also find the fastest DNP online program options and choose pathways that fit their busy schedules.

If research or traditional dissertations aren’t your preferred path, there are also flexible online DNP programs without dissertation requirements. Whether you’re interested in administration, nursing, or advanced practice, these programs provide accessible routes to leadership roles in healthcare, catering to various professional goals and lifestyles.

Best Scientists Citing Bernd Schnabl

Trending Scientists

Recently Published Articles